Healthcare -
Biotechnology - NASDAQ - US
$ 39.24
4.39 %
$ 2.41 B
Market Cap
9.28
P/E
PTGX - STOCK-BASED COMPENSATION
Stock-based Compensation PTGX - Protagonist Therapeutics, Inc.
29.3 M
LAST VALUE
33.67%
2 YEAR CAGR
33.46%
5 YEAR CAGR
0.00%
10 YEAR CAGR